Lecture 3 - Mono and Multi-Exponential Pharmacokinetic Models

Week Two: Mono and Multi-Exponential Pharmacokinetic Models *NOTE : Equations in slides

Review of Previous Lecture

  • Discussion of foundations of pharmacokinetics.

    • Key concepts covered:

    • ADME (Absorption, Distribution, Metabolism, Excretion)

    • Clearance

    • Half-life

    • Importance of pharmacokinetics in clinical decision-making.

Learning Objectives for Today

  • Understand the relationship between drug concentration and time.

  • Distinguish mono-exponential from multi-exponential decline in pharmacokinetics.

  • Define and calculate various pharmacokinetic parameters:

    • Clearance

    • Volume of distribution

    • Elimination rate constant

    • Area under curve (AUC)

    • Half-life

  • Interpret pharmacokinetic data to predict drug behavior.

Definition and Importance of Pharmacokinetic Models

  • Pharmacokinetic Models:

    • Mathematical representations of how drug concentrations change over time.

    • Important due to complex body dynamics; simplifies drug behavior into compartments (not real anatomical spaces).

Mono-Exponential Pharmacokinetics
  • Mono-Exponential Model:

    • Assumes the body as a single compartment, with:

    1. First-order kinetics (elimination rate proportional to drug concentration).

    2. Instantaneous absorption (immediate availability in systemic circulation).

    3. Linear pharmacokinetics (parameters constant with dose/time).

    4. Elimination occurs from the central compartment only; no saturation.

  • Graphical Representation:

    • Initial concentration decreases exponentially over time.

    • Requires plot on a logarithmic scale for analysis (results in a straight line).

  • Key equation:

    • Ct=C0ekt

    • where:

      • CtC_t = concentration at time tt

      • C0C_0 = initial concentration

      • kk = elimination rate constant

      • tt = time.

  • After applying logarithm,

    • extlog(C)=extlog(C0)rack2.303text{log}(C) = ext{log}(C_0) - rac{k}{2.303} t

    • where the slope equals k-k.

Pharmacokinetic Parameters

  1. Elimination Rate Constant (k)

    • Represents fraction of drug eliminated per unit time (units: time⁻¹).

    • Determines how quickly a drug is eliminated:

      • High kk = rapid elimination

      • Low kk = slow elimination.

    • Calculation Methods:

      • Log-linear plot (slope method) to determine kk directly from the slope.

      • Two-point method (using two concentrations):

      • k=racextln(C<em>1)extln(C</em>2)T<em>2T</em>1k = rac{ ext{ln}(C<em>1) - ext{ln}(C</em>2)}{T<em>2 - T</em>1}

      • Example with values: C<em>1=18extmg/L,C</em>2=6extmg/L,T<em>1=3exthours,T</em>2=8exthoursC<em>1 = 18 ext{ mg/L}, C</em>2 = 6 ext{ mg/L}, T<em>1 = 3 ext{ hours}, T</em>2 = 8 ext{ hours}.

      • Half-life method:

      • k=rac0.693T1/2k = rac{0.693}{T_{1/2}}

        • where T1/2T_{1/2} is the half-life.

      • Clearance and volume of distribution method using density parameters.

  2. Half-life (T_{1/2})

    • Time required for the concentration to decrease by 50%.

    • In the mono-exponential model, half-life is constant.

    • Formula:

      • T1/2=rac0.693kT_{1/2} = rac{0.693}{k} .

    • Important rule:

      • Drug reaches steady state in 5-7 half-lives.

    • Time for washout is also 5-7 half-lives.

  3. Volume of Distribution (VD)

    • Apparent volume into which the drug distributes; indicates degree of drug affinity.

    • Units: extmLext{mL} or extL/kgext{L/kg}.

    • High V<em>DV<em>D suggests widespread tissue distribution; low V</em>DV</em>D indicates confinement in plasma.

    • Formula:

      • VD=racextDoseextConcentrationV_D = rac{ ext{Dose}}{ ext{Concentration}}.

    • Determines loading dose:

      • extLoadingDose=V<em>DimesC</em>Text{Loading Dose} = V<em>D imes C</em>T.

  4. Clearance (Cl)

    • Volume of plasma cleared of drug per unit time; describes efficiency of elimination.

    • Units: extL/hourext{L/hour}.

    • Critical for determining maintenance dose:

      • extMaintenanceDose=extClearanceimesCssext{Maintenance Dose} = ext{Clearance} imes C_{ss} (steady state concentration).

    • Calculation using different equations for situational clarity:

      • Cl=kimesVDCl = k imes V_D,

      • Cl=racextDoseextAUCCl = rac{ ext{Dose}}{ ext{AUC}}.

  5. Area Under Curve (AUC)

    • Reflects total drug exposure over time when plasma concentration is plotted against time.

    • High AUC indicates greater bioavailability.

    • Calculation Methods:

      • Analytical formulas for IV bolus:

      • AUC=racC0kAUC = rac{C_0}{k}

      • Trapezoidal method for graphical data:

      1. Divide into trapezoids for calculation.

      2. Total the areas for comprehensive AUC.

Recap on Mono-Exponential Model

  • Summary:

    • Assumes single compartment; characterized by first-order elimination and single half-life.

    • Primary utility in rapidly distributing drugs.

Introduction to Multi-Exponential Models

  • Multi-Exponential Pharmacokinetics:

    • Used when drug eliminates according to more than one exponential decline (i.e., non-homogeneous distribution).

    • Model subdivided into:

    • Distribution phase (alpha phase) - rapid drop in concentration as drug distributes.

    • Elimination phase (beta phase) - slower decline as drug is eliminated.

  • Two Compartment Model:

    • Assumes central compartment (blood) and peripheral compartments (tissues).

    • Drug moves rapidly from the central to peripheral compartments before reaching equilibrium.

    • Utilizes two distinct rate constants:

    • Alpha: Distribution rate constant.

    • Beta: Elimination rate constant.

  • Equations:

    • Ct=Aeextalphat+BeextbetatC_t = A e^{- ext{alpha} t} + B e^{- ext{beta} t} .

    • Key Parameters in multi-compartment modeling:

    1. Alpha: Rapid distribution; determined by K<em>12K<em>{12} and K</em>21K</em>{21}.

    2. Beta: Terminal elimination; clinically relevant for determining half-life.

Mathematical Concepts and Methods in Multi-Exponential Models
  • Method of Residuals:

    • Used to separate distribution and elimination curves for clearer interpretation.

    • Allows calculation of distribution parameters.

Conclusion

  • The understanding of pharmacokinetic models facilitates informed decisions in clinical settings regarding dosages, potential toxicity risks, and adjustments based on physiological changes or disease states.

  • Mono-exponential models provide a framework for understanding rapidly distributing drugs while multi-exponential models serve for those that exhibit more complex behaviors.

Next Lecture

  • Focus on IV infusion and steady state.

  • Prepare questions for Q&A sessions following today's lecture!